News Agency
Men's Weekly

Senhwa Biosciences Received US FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection

  • Written by PR Newswire
Senhwa Biosciences Received US FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection

TAIPEI, Nov. 21, 2023 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that U.S. Food and Drug Administration has approved its Phase II IND application of Silmitasertib(CX-4945) to treat patients with...

Read more: Senhwa Biosciences Received US FDA IND Approval for Phase II Study of Silmitasertib in Patients...

Commercial Scaffolding Services and the Backbone of Large-Scale Projects

Large construction projects rely on more than concrete and steel to rise safely and efficiently. Commercial scaffolding services form the temporary framework that allows complex work to happen at height, supporting trades, materials, and workflows across multi-level sites. From early... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion